Launch

Value Partners launches AI+Life Sciences CVC fund

What's the deal? Value Partners GroupDealroom has a profile for this one. Try Dealroom → announced on Tuesday plans to launch a yuan-denominated corporate venture capital fund focused on "AI+Life Sciences." It is joining forces with Insilico Medicine, Shanghai Pudong DevelopmentDealroom has a profile for this one. Try Dealroom →, and Shanghai Pudong ConstructionDealroom has a profile for this one. Try Dealroom →.

The fund will target collaborative industrial investments across the AI and life sciences ecosystem. Value PartnersDealroom has a profile for this one. Try Dealroom →' onshore licensed manager, Value Partners Private Equity Investment (Shenzhen)Dealroom has a profile for this one. Try Dealroom →, will act as general partner and fund manager.

Why now? Leung Chuen-yan, partner and private investments at Value Partners, said life sciences stands out for its "highest data density, the most complete validation cycles, and the clearest path to commercialisation."

The partners bring different strengths. Shanghai Pudong is a hub for both life sciences and AI, and the two Pudong groups add industrial platforms and regional ecosystem knowledge, Leung said.

What's the endgame? Li Junlan, chairperson of Pudong Development GroupDealroom has a profile for this one. Try Dealroom →, said the fund marks a new phase of collaboration with Insilico Medicine, moving from industrial implementation to capital and ecosystem integration. The goal: building a globally influential AI-life sciences cluster in Pudong.

Alex Zhavoronkov, founder and co-chief executive officer of Insilico Medicine, said the company aims to combine capital, industry insights, and resources to "reduce early-stage innovation risk" and speed commercialisation of breakthroughs.

The signal: The fund reflects growing appetite for pooling industrial capital behind AI-driven drug discovery in China, tying frontier research to established regional platforms and a clear commercial path.

Read more: The Standard

Image credit: frans16611

More top stories